Frequently Asked Questions
The market is segmented based on Middle East and Africa Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables and Accessories and Services and Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others), Type (Antibacterial Testing, Antifungal Testing and Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others), End-User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes and Others), Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor) - Industry Trends and Forecast to 2030.
.
The Middle East Africa Antimicrobial Susceptibility Testing Market size was valued at USD 99.83 USD Million in 2022.
The Middle East Africa Antimicrobial Susceptibility Testing Market is projected to grow at a CAGR of 4.5% during the forecast period of 2023 to 2030.
The major players operating in the market include , BD , Synbiosis , Zhuhai DL Biotech Co. Ltd , Mast Group , HiMedia Laboratories , Thermo Fisher Scientific , Bio,Rad Laboratories , Creative Diagnostics , Genefluidics , Rosco Diagnostica A/S , ERBA Group , Liofilchem S.r.l. , Alifax S.r.l. , MERLIN Gesellschaft für mikrobiologische Diagnostika mbH , bioMérieux SA , Merck KGaA , Danaher , Accelerate Diagnostics , NuMedii , BacterioScan ,.
The market report covers data from the South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
